Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 3
1997 1
1998 1
2010 1
2011 4
2012 1
2013 1
2014 1
2015 2
2016 2
2018 3
2019 3
2020 3
2021 5
2022 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies.
Iaffaldano P, Lucisano G, Caputo F, Paolicelli D, Patti F, Zaffaroni M, Brescia Morra V, Pozzilli C, De Luca G, Inglese M, Salemi G, Maniscalco GT, Cocco E, Sola P, Lus G, Conte A, Amato MP, Granella F, Gasperini C, Bellantonio P, Totaro R, Rovaris M, Salvetti M, Torri Clerici VLA, Bergamaschi R, Maimone D, Scarpini E, Capobianco M, Comi G, Filippi M, Trojano M; Italian MS Register. Iaffaldano P, et al. Among authors: bellantonio p. Ther Adv Neurol Disord. 2021 May 31;14:17562864211019574. doi: 10.1177/17562864211019574. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34104220 Free PMC article.
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis.
Gilio L, Fresegna D, Gentile A, Guadalupi L, Sanna K, De Vito F, Balletta S, Caioli S, Rizzo FR, Musella A, Iezzi E, Moscatelli A, Galifi G, Fantozzi R, Bellantonio P, Furlan R, Finardi A, Vanni V, Dolcetti E, Bruno A, Buttari F, Mandolesi G, Centonze D, Stampanoni Bassi M. Gilio L, et al. Among authors: bellantonio p. Neurobiol Dis. 2022 Oct 1;172:105817. doi: 10.1016/j.nbd.2022.105817. Epub 2022 Jul 11. Neurobiol Dis. 2022. PMID: 35835361 Free article.
COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab.
Buttari F, Bruno A, Dolcetti E, Azzolini F, Bellantonio P, Centonze D, Fantozzi R. Buttari F, et al. Among authors: bellantonio p. Mult Scler Relat Disord. 2021 Jul;52:102983. doi: 10.1016/j.msard.2021.102983. Epub 2021 May 4. Mult Scler Relat Disord. 2021. PMID: 33990054 Free PMC article.
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis.
Stampanoni Bassi M, Nuzzo T, Gilio L, Miroballo M, Casamassa A, Buttari F, Bellantonio P, Fantozzi R, Galifi G, Furlan R, Finardi A, De Rosa A, Di Maio A, Errico F, Centonze D, Usiello A. Stampanoni Bassi M, et al. Among authors: bellantonio p. J Neurochem. 2021 Dec;159(5):857-866. doi: 10.1111/jnc.15518. Epub 2021 Oct 9. J Neurochem. 2021. PMID: 34547109 Free article.
Obesity worsens central inflammation and disability in multiple sclerosis.
Stampanoni Bassi M, Iezzi E, Buttari F, Gilio L, Simonelli I, Carbone F, Micillo T, De Rosa V, Sica F, Furlan R, Finardi A, Fantozzi R, Storto M, Bellantonio P, Pirollo P, Di Lemme S, Musella A, Mandolesi G, Centonze D, Matarese G. Stampanoni Bassi M, et al. Among authors: bellantonio p. Mult Scler. 2020 Sep;26(10):1237-1246. doi: 10.1177/1352458519853473. Epub 2019 Jun 4. Mult Scler. 2020. PMID: 31161863
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients.
Stampanoni Bassi M, Buttari F, Maffei P, De Paolis N, Sancesario A, Gilio L, Pavone L, Pasqua G, Simonelli I, Sica F, Fantozzi R, Bellantonio P, Centonze D, Iezzi E. Stampanoni Bassi M, et al. Among authors: bellantonio p. Clin Neurophysiol. 2020 Feb;131(2):566-573. doi: 10.1016/j.clinph.2019.10.023. Epub 2019 Nov 21. Clin Neurophysiol. 2020. PMID: 31818686
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.
Bergamaschi R, Beghi E, Bosetti C, Ponzio M, Santucci C, Lepore V, Mosconi P; Italian Multiple Sclerosis and Related Disorders Register Centers Group and the Scientific Committee of Italian SM and Related Disorders Register; Aguglia U, Amato MP, Ancona AL, Ardito B, Avolio C, Balgera R, Banfi P, Barcella V, Barone P, Bellantonio P, Berardinelli A, Bergamaschi R, Bertora P, Bianchi M, Bramanti P, Morra VB, Brichetto G, Brioschi AM, Buccafusca M, Bucello S, Busillo V, Calchetti B, Cantello R, Capobianco M, Capone F, Capone L, Cargnelutti D, Carrozzi M, Cartechini E, Cavaletti G, Cavalla P, Celani MG, Clerici R, Clerico M, Cocco E, Confalonieri P, Coniglio MG, Conte A, Corea F, Cottone S, Crociani P, D'Andrea F, Danni MC, De Luca G, de Pascalis D, De Riz M, De Robertis F, De Rosa G, De Stefano N, Corte MD, Di Sapio A, Docimo R, Falcini M, Falcone N, Fermi S, Ferraro E, Ferrò MT, Fortunato M, Foschi M, Gajofatto A, Gallo A, Gallo P, Gatto M, Gazzola P, Giordano A, Granella F, Grasso MF, Grasso MG, Grimaldi LME, Iaffaldano P, Imperiale D, Inglese M, Iodice R, Leva S, Luezzi V, Lugaresi A, Lus G, Maimone D, Mancinelli L, Maniscalco GT, Marfia GA, Marini B, Marson A, Mascoli N, Ma… See abstract for full author list ➔ Bergamaschi R, et al. Among authors: bellantonio p. Neurol Sci. 2022 Sep;43(9):5459-5469. doi: 10.1007/s10072-022-06169-7. Epub 2022 Jun 7. Neurol Sci. 2022. PMID: 35672479 Free PMC article.
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients.
Stampanoni Bassi M, Drulovic J, Pekmezovic T, Iezzi E, Sica F, Gilio L, Gentile A, Musella A, Mandolesi G, Furlan R, Finardi A, Marfia GA, Bellantonio P, Fantozzi R, Centonze D, Buttari F. Stampanoni Bassi M, et al. Among authors: bellantonio p. Ther Adv Neurol Disord. 2020 Dec 8;13:1756286420970833. doi: 10.1177/1756286420970833. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 33343708 Free PMC article.
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study.
Chisari CG, Comi G, Filippi M, Paolicelli D, Iaffaldano P, Zaffaroni M, Brescia Morra V, Cocco E, Marfia GA, Grimaldi LM, Inglese M, Bonavita S, Lugaresi A, Salemi G, De Luca G, Cottone S, Conte A, Sola P, Aguglia U, Maniscalco GT, Gasperini C, Ferrò MT, Pesci I, Amato MP, Rovaris M, Solaro C, Lus G, Maimone D, Bergamaschi R, Granella F, Di Sapio A, Bertolotto A, Totaro R, Vianello M, Cavalla P, Bellantonio P, Lepore V, Patti F; Italian MS Register Study Group.. Chisari CG, et al. Among authors: bellantonio p. J Neurol. 2022 Feb;269(2):933-944. doi: 10.1007/s00415-021-10676-6. Epub 2021 Jun 28. J Neurol. 2022. PMID: 34181077
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis.
Stampanoni Bassi M, Gilio L, Iezzi E, Moscatelli A, Pekmezovic T, Drulovic J, Furlan R, Finardi A, Mandolesi G, Musella A, Galifi G, Fantozzi R, Bellantonio P, Storto M, Centonze D, Buttari F. Stampanoni Bassi M, et al. Among authors: bellantonio p. Front Aging Neurosci. 2021 Sep 10;13:694651. doi: 10.3389/fnagi.2021.694651. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34566620 Free PMC article.
29 results